Corient Private Wealth
INSM icon

Corient Private Wealth’s Insmed INSM Stock Holding History

Corient Private Wealth’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.95M Buy
30,249
+4,394
+17% +$676K 0.01% 847
2025
Q4 		$4.5M Buy
25,855
+10,295
+66% +$1.88M ﹤0.01% 1103
2025
Q3 		$2.24M Buy
15,560
+536
+4% +$65.7K ﹤0.01% 1015
2025
Q2 		$1.51M Buy
15,024
+2,705
+22% +$207K ﹤0.01% 1170
2025
Q1 		$940K Sell
12,319
-2,411
-16% -$184K ﹤0.01% 1304
2024
Q4 		$1.02M Buy
14,730
+3,747
+34% +$270K ﹤0.01% 1315
2024
Q3 		$802K Buy
10,983
+4,223
+62% +$312K ﹤0.01% 1510
2024
Q2 		$453K Buy
+6,760
New +$262K ﹤0.01% 1704
2023
Q4 		– Sell
-10,218
Closed -$258K – 2297
2023
Q3 		$258K Buy
+10,218
New +$234K ﹤0.01% 1813

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Corient Private Wealth's INSM Position: Q1 2026 in Review

Corient Private Wealth increased its Insmed (INSM) stake by 17% in Q1 2026, buying an estimated $676K and bringing the position to 30,249 shares worth $4.95M. The position accounts for 0.01% of the portfolio, ranked #847.

Corient Private Wealth first reported a position in INSM in Q3 2023 and has held it in 9 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Corient Private Wealth held 30,249 shares of Insmed worth $4.95M as of Q1 2026.
  • Corient Private Wealth bought 4,394 Insmed shares in Q1 2026, an estimated $676K.
  • Insmed made up 0.01% of Corient Private Wealth's portfolio in Q1 2026, its #847 holding.
  • Corient Private Wealth first reported a position in Insmed in Q3 2023 and has held it in 9 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.